Latest Articles
Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies - StreetInsider
Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies StreetInsider
Published: June 11, 2026, 5:42 a.m.
Oldham expert warns endometriosis may be linked to serious neurological issues - Oldham Times
Oldham expert warns endometriosis may be linked to serious neurological issues Oldham Times
Published: June 11, 2026, 4 a.m.
Continence Underwear Designs - Trend Hunter
Continence Underwear Designs Trend Hunter
Published: June 11, 2026, 12:02 a.m.
Charles Drew University Students Create Award-Winning Device for Earlier Endometriosis Detection - LA Focus
Charles Drew University Students Create Award-Winning Device for Earlier Endometriosis Detection LA Focus
Published: June 10, 2026, 11:38 p.m.
New regional Qld endometriosis clinic launched - The Cairns Post
New regional Qld endometriosis clinic launched The Cairns Post
Published: June 10, 2026, 10 p.m.
Breast cancer and endometriosis drug Zoladex is being pulled from Australia. How will women be affected? - The Guardian
Breast cancer and endometriosis drug Zoladex is being pulled from Australia. How will women be affected? The Guardian
Published: June 10, 2026, 9:17 p.m.
New less invasive treatments expand care options for women with endometriosis and fibroids - SKNVibes
New less invasive treatments expand care options for women with endometriosis and fibroids SKNVibes
Published: June 10, 2026, 7:58 p.m.
Oxford University Press Launches New Textbook on Interventional Pain Medicine for Women's Health with Dr. Anita Gupta - USA Today
Oxford University Press Launches New Textbook on Interventional Pain Medicine for Women's Health with Dr. Anita Gupta USA Today
Published: June 10, 2026, 7 p.m.
FDA’s drug repurposing initiative signals renewed focus - Drug Discovery News
FDA’s drug repurposing initiative signals renewed focus Drug Discovery News
Published: June 10, 2026, 6:26 p.m.
Four-Year RUBY Data Support Curative Intent With Dostarlimab in dMMR/MSI-H Endometrial Cancer - The ASCO Post
Four-Year RUBY Data Support Curative Intent With Dostarlimab in dMMR/MSI-H Endometrial Cancer The ASCO Post
Published: June 10, 2026, 4:41 p.m.
Link copied to clipboard!